ImmuneOncia Therapeutics, Inc.
A biopharma firm developing immune checkpoint inhibitors for cancer immunotherapy.
424870 | KO
Overview
Corporate Details
- ISIN(s):
- KR7424870004
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 탑실로35번길 25, 용인시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ImmuneOncia Therapeutics, Inc. is a clinical-stage, immuno-oncology-centric biopharmaceutical company dedicated to developing cutting-edge immunotherapies for cancer treatment. Established in 2016 as a joint venture between Yuhan Corporation and Sorrento Therapeutics, the company leverages expertise in drug development and antibody engineering. ImmuneOncia's pipeline focuses on developing immune checkpoint inhibitors targeting T cells and macrophages. Its portfolio includes IMC-001, its lead candidate, and IMC-002, a fully human anti-CD47 monoclonal antibody for various cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 887.8 KB | ||
| 2025-05-30 00:00 |
Share Issue/Capital Change
주식매수선택권행사
|
Korean | 43.9 KB | ||
| 2025-05-23 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 102.9 KB | ||
| 2025-05-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-05-12 00:00 |
Share Issue/Capital Change
증권발행실적보고서
|
Korean | 323.5 KB | ||
| 2025-04-30 00:00 |
Registration Form
[발행조건확정]증권신고서(지분증권)
|
Korean | 525.5 KB | ||
| 2025-04-30 00:00 |
Prospectus
[기재정정]투자설명서
|
Korean | 3.9 MB | ||
| 2025-04-28 00:00 |
Prospectus
투자설명서
|
Korean | 3.3 MB | ||
| 2025-04-18 00:00 |
Registration Form
[기재정정]증권신고서(지분증권)
|
Korean | 3.4 MB | ||
| 2025-04-17 00:00 |
Registration Form
[기재정정]증권신고서(지분증권)
|
Korean | 4.2 MB | ||
| 2025-04-04 00:00 |
Registration Form
[기재정정]증권신고서(지분증권)
|
Korean | 3.9 MB | ||
| 2025-04-02 00:00 |
Registration Form
[기재정정]증권신고서(지분증권)
|
Korean | 3.5 MB | ||
| 2025-03-28 00:00 |
Annual / Quarterly Financial Statement
감사보고서 (2024.12)
|
Korean | 397.2 KB | ||
| 2025-03-14 00:00 |
Registration Form
증권신고서(지분증권)
|
Korean | 3.1 MB | ||
| 2024-04-08 00:00 |
Annual / Quarterly Financial Statement
감사보고서 (2023.12)
|
Korean | 355.7 KB |
Automate Your Workflow. Get a real-time feed of all ImmuneOncia Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ImmuneOncia Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ImmuneOncia Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}